Author Guidelines
1. SUBMISSION
Thank you for your interest in Nephrology. Authors should kindly note that submission implies (i) that the content has not been published previously, in any language, in whole or in part, except as a brief abstract in the proceedings of a scientific meeting or symposium; and (ii) that the manuscript is not currently under consideration for publication elsewhere.
Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at http://MC.manuscriptcentral.com/nep
Click here for more details on how to use ScholarOne.
Preprint policy
Please find the Wiley preprint policy here.
Nephrology accepts articles previously published on preprint servers. The journal will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.
2. AIMS AND SCOPE
Nephrology is the official journal of the Asian Pacific Society of Nephrology, and publishes manuscripts of international interest describing original research concerned with clinical and experimental aspects of nephrology. We welcome submissions in the forms of original research articles, brief communications, instructive cases and letters to the editor and solicit review articles and editorials.
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
i. Original Articles
Word limit: 4,000 words maximum including abstract
Abstract: 250 words maximum and must include subheadings
References: In general, less than 30.
Figures/Tables: Total of no more than 8 figures and tables.
Description: Full-length reports of current research in either basic or clinical science.
ii. Brief Communications
Word limit: 2,000 words maximum including abstract
Abstract: 250 words maximum, unstructured
References: In general, less than 20
Figures/Tables: Total of no more than 3 figures and tables
Description: Brief communications of exceptional merit, both clinical and experimental, may be given rapid publication.
iii. Review Articles
Word limit: 4,000 words maximum including abstract
Abstract: 250 words maximum, unstructured
References: No limit
Figures/Tables: Total of no more than 8 figures and tables.
Description: Reviews are comprehensive analyses of specific topics. They are usually submitted upon invitation by the Editors. Both solicited and unsolicited review articles will undergo peer review prior to acceptance.
iv. Correspondence (Instructive Cases)
Word limit: 500 word maximum, or 400 words maximum with one table or figure
References: 5 maximum
Figures/Tables: 1 single panel figure or 1 table
Instructive Cases should be submitted as Correspondence and will be published in the Correspondence section. Items in the Correspondence section should not contain an abstract, keywords or section headings. Contributions to this section will not undergo peer review but will be assessed by the Editorial team.
v. Editorials (only by invitation of Editors).
Word limit: 1,000 words maximum
Abstract: No abstract required for this manuscript type
References: 5 maximum
Description: Proposals for Editorials may be submitted; however, in this case authors should only send an outline of the proposed paper for initial consideration.
4. PREPARING THE SUBMISSION
STYLE
Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors’ revised ‘Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication’, as presented at http://www.ICMJE.org/.
Spelling. The journal uses UK spelling and authors should therefore follow the latest edition of the Concise Oxford Dictionary.
Units. All measurements must be given in SI or SI-derived units. Please go to the Bureau International des Poids et Mesures (BIPM) website at http://www.bipm.fr for more information about SI units.
Abbreviations. Abbreviations should be used sparingly – only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Trade names. Chemical substances should be referred to by the generic name only. Trade names should not used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name, and the name and location of the manufacturer, in parentheses.
Genetic nomenclature. Standard genetic nomenclature should be used. For further information, including relevant websites, authors should refer to the genetic nomenclature guide in Trends in Genetics (Elsevier Science, 1998).
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345.’
Addresses are as follows:
DNA Data Bank of Japan (DDBJ) http://www.ddbj.nig.ac.jp
EMBL Nucleotide Sequence Submissions http://www.ebi.ac.uk
GenBank http://www.ncbi.nlm.nih.gov
PARTS OF THE MANUSCRIPT
The manuscript should be submitted in separate files: title page; main text file; figures.
The length of manuscripts must adhere to the specifications under the section Manuscript Categories.
Manuscripts submitted as Original Articles, Review Articles and Brief Communications, should be presented in the following order:
(i) title page;
(ii) abstract and key words;
(iii) text;
(iv) acknowledgments;
(v) references;
(vi) supporting information legend (if relevant);
(vii) figure legends; and
(viii) tables (each table complete with title and footnotes).
Figures and supporting information should be submitted as separate files. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
Title page
The title page should contain:
(i) a short informative title that contains the major key words. The title should not contain abbreviations;
(ii) the full names of the authors;
(iii) the author's institutional affiliations at which the work was carried out;
(iv) the full postal and email address, plus telephone number, of the author to whom correspondence about the manuscript should be sent;
(v) a short running title (less than 40 characters).
The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.
Abstract and key words
Original articles must have a structured abstract that states in 250 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. Divide the abstract with the headings: Aim, Methods, Results, Conclusion. Review Articles and Brief Communications should have an unstructured abstract of 250 words or fewer. The abstract should not contain abbreviations or references.
Five key words, for the purposes of indexing, should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at http://www.nlm.nih.gov/mesh/meshhome.html.
Acknowledgements
The source of financial grants and other funding must be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Personal thanks and thanks to anonymous reviewers are not appropriate.
Conflict of Interest
All authors are asked to sign a Competing Interests and Acknowledgment Statement on submission of their manuscript.
References
All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. Sample references follow:
Journal article:
King VM, Armstrong DM, Apps R, Trott JR. Numerical aspects of pontine, lateral reticular, and inferior olivary projections to two paravermal cortical zones of the cat cerebellum.J Comp Neurol1998;390:537-551.
Book:
Voet D, Voet JG.Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.
Please note that journal title abbreviations should conform to the practices of Chemical Abstracts.
For more information about AMA reference style -AMA Manual of Style
Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Number tables consecutively in the text in Arabic numerals. Type tables on a separate page with the legend above. Legends should be concise but comprehensive – the table, legend and footnotes must be understandable without reference to the text. Vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figure legends
Type figure legends on a separate page. Legends should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Figures
All illustrations (line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Magnifications should be indicated using a scale bar on the illustration. Each figure should be supplied as a separate file, with the figure number incorporated in the file name.
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.
Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Supporting Information
Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc. Click here for Wiley’s FAQs on supporting information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
Wiley Author Resources
Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.
Editing, Translation, and Formatting Support: Wiley Editing Services can greatly improve the chances of a manuscript being accepted. Offering expert help in English language editing, translation, manuscript formatting, and figure preparation, Wiley Editing Services ensures that the manuscript is ready for submission.
SUBMISSION REQUIREMENTS
Manuscripts should be submitted online at http://MC.manuscriptcentral.com/nep
• Covering letter. Papers are accepted for publication in the journal on the understanding that the content has not been published or submitted for publication elsewhere. This must be stated in the covering letter.
The covering letter must also contain an acknowledgement that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be quantified.
• Authors must declare any financial support or relationships that may pose conflict of interest by disclosing at the time of submission any financial arrangements they have with a company whose product figures prominently in the submitted manuscript or with a company making a competing product. Such information will be held in confidence while the paper is under review and will not influence the editorial decision but, if the article is accepted for publication, the Editor will usually discuss with the authors the manner in which such information is to be communicated to the reader.
• Two Word-files need to be included upon submission: A title page file and a main text file that includes all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.
• The main text file should be prepared using Microsoft Word, doubled-spaced.
• Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files will be required.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to our readership. Except where otherwise stated, manuscripts are peer reviewed by two anonymous reviewers and the Editor. Final acceptance or rejection rests with the Editorial Board, who reserves the right to refuse any material for publication.
Manuscripts should be written in a clear, concise, direct style. Where contributions are judged as acceptable for publication on the basis of scientific content, the Editor and the Publisher reserve the right to modify typescripts to eliminate ambiguity and repetition and improve communication between author and reader.
In-house submissions, i.e. papers authored by Editors or Editorial Board members of the title, will be sent to Editors unaffiliated with the author or institution and monitored carefully to ensure there is no peer review bias.
Wiley's policy on the confidentiality of the review process is available here.
Principles for Publication of Research Involving Human Subjects
Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at http://www.wma.net/en/30publications/10policies/b3/index.html. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study. Details that might disclose the identity of the subjects under the study should be omitted.
Use of Animals in Research
Any experiments involving animals must be demonstrated to be ethically acceptable and where relevant conform to national guidelines for animal usage in research.
Clinical Trial Registration
Nephrology requires that the clinical trials submitted for its consideration are registered in a publicly accessible database. Authors should include the name of the trial register and their clinical trial registration number in the Acknowledgements section of their manuscript. If you wish the editor[s] to consider an unregistered trial, please explain briefly why the trial has not been registered.
Randomized Controlled Trials
Reporting of randomized controlled trials should follow the guidelines of The CONSORT Statement: http://www.consort-statement.org
Authorship and Acknowledgements
The journal adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria: i) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; ii) Drafting the work or revising it critically for important intellectual content; iii) Final approval of the version to be published; and i) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Contributors who do not qualify as authors should be mentioned under ‘Acknowledgements’.
Correction to authorship
In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Nephrology will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]
Publication Ethics
This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read the Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found at authorservices.wiley.com/ethics-guidelines/index.html.
Data Sharing and Data Accessibility
The journal encourages authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.
6. AUTHOR LICENSING
If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.
General information regarding licensing and copyright is available here.
Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.
Open Access: This journal is a subscription journal that offers an open access option. You’ll have the option to choose to make your article open access after acceptance, which will be subject to an APC. You can read more about APCs and whether you may be eligible for waivers or discounts, through your institution, funder, or a country waiver.
Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted Article Received in Production
When an accepted article is received by Wiley's production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.
Accepted Articles
The journal offers Wiley’s Accepted Articles service for all manuscripts. This service ensures that accepted ‘in press’ manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After print publication, the DOI remains valid and can continue to be used to cite and access the article. The Accepted Articles service has been designed to ensure the earliest possible circulation of research papers after acceptance. Given that copyright licensing is a condition of publication, a completed copyright form is required before a manuscript can be processed as an Accepted Article. Accepted articles will be indexed by PubMed; therefore the submitting author must carefully check the names and affiliations of all authors provided in the cover page of the manuscript, as it will not be possible to alter these once a paper is made available online in Accepted Article format. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.
Proofing
Authors will receive an e-mail notification with a link and instructions for accessing HTML page proofs online. Page proofs should be carefully proofread for any copyediting or typesetting errors. Online guidelines are provided within the system. No special software is required, all common browsers are supported. Authors should also make sure that any renumbered tables, figures, or references match text citations and that figure legends correspond with text citations and actual figures. Proofs must be returned within 48 hours of receipt of the email. Return of proofs via e-mail is possible in the event that the online system cannot be used or accessed.
Early View
The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.
8. POST PUBLICATION
Access and Sharing
When the article is published online:
The author receives an email alert (if requested).
The link to the published article can be shared through social media.
The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.
Print copies of the article can now be ordered (instructions are sent at proofing stage or email www.sheridan.com/wiley/eoc)
To find out how to best promote an article, click here.
Measuring the Impact of an Article
Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.
Author Name Change Policy
In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.
9. EDITORIAL OFFICE CONTACT DETAILS
Editorial Office, Nephrology
155 Cremorne Street
Richmond, Victoria 3121
Australia
Email: nep.eo@wiley.com; fax: +61 3 9274 3390.
Author Guidelines updated 13 May 2021
